Pexelizumab: reduced mortality rate after acute MI

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1373, 2003-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pexelizumab: lower MI, mortality rates after CABG

By  

Inpharma, Vol. 1, Iss. 1421, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Eplerenone reduces morbidity, mortality after acute MI

By  

Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Disheartening results for pexelizumab in acute STEMI

By  

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Inappropriate -blocker prescribing after acute myocardial infarction (MI) is associated with greater mortality than appropriate prescribing

By  

Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Sertraline for depression after acute MI

By  

Inpharma, Vol. 1, Iss. 1352, 2002-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite